Didesmethyl erlotinib hydrochloride salt
CAS: 183320-12-9
Ref. 3D-FD21742
| 1mg | A consultar | ||
| 5mg | A consultar | ||
| 10mg | A consultar |
Información del producto
- 2,2'-[[4-[(3-Ethynylphenyl)amino]-6,7-quinazolinediyl]bis(oxy)]bis-ethanol monohydrochloride
- 2,2[[4-[(3-Ethynylphenyl)amino]-6,7-quinazolinediyl]bis(oxy)]bis-ethanol Monohydrochloride
- 2,2'-[{4-[(3-Ethynylphenyl)Amino]Quinazoline-6,7-Diyl}Bis(Oxy)]Diethanol Hydrochloride
Didesmethyl erlotinib hydrochloride salt is a cytotoxic drug used in the treatment of cancer. It is a prodrug that is metabolized to an active form, which inhibits the activity of tyrosine kinases, leading to cell death. Didesmethyl erlotinib hydrochloride salt binds to the enzyme elution and then reacts with oxygen, forming a reactive intermediate. This intermediate reacts with deuterated acetonitrile in LC-MS/MS to produce a deuterated adduct that can be monitored using mass spectrometry. The reaction between didesmethyl erlotinib hydrochloride salt and oxygen leads to the formation of two adducts, one of which has been identified as the product of oxidation at C2 and C3. The other adduct has not yet been identified but could be due to oxidation at C1 and C2 or C1 and C3.
Propiedades químicas
Consulta técnica sobre: 3D-FD21742 Didesmethyl erlotinib hydrochloride salt
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
